Cargando…
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts
Objectives: Systemic sclerosis (SSc) is a connective tissue disorder presenting fibrosis of the skin and internal organs, for which no effective treatments are currently available. Increasing evidence indicates that the P2X7 receptor (P2X7R), a nucleotide-gated ionotropic channel primarily involved...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602350/ https://www.ncbi.nlm.nih.gov/pubmed/28955239 http://dx.doi.org/10.3389/fphar.2017.00638 |
_version_ | 1783264558203273216 |
---|---|
author | Gentile, Daniela Lazzerini, Pietro E. Gamberucci, Alessandra Natale, Mariarita Selvi, Enrico Vanni, Francesca Alì, Alessandra Taddeucci, Paolo Del-Ry, Silvia Cabiati, Manuela Della-Latta, Veronica Abraham, David J. Morales, Maria A. Fulceri, Rosella Laghi-Pasini, Franco Capecchi, Pier L. |
author_facet | Gentile, Daniela Lazzerini, Pietro E. Gamberucci, Alessandra Natale, Mariarita Selvi, Enrico Vanni, Francesca Alì, Alessandra Taddeucci, Paolo Del-Ry, Silvia Cabiati, Manuela Della-Latta, Veronica Abraham, David J. Morales, Maria A. Fulceri, Rosella Laghi-Pasini, Franco Capecchi, Pier L. |
author_sort | Gentile, Daniela |
collection | PubMed |
description | Objectives: Systemic sclerosis (SSc) is a connective tissue disorder presenting fibrosis of the skin and internal organs, for which no effective treatments are currently available. Increasing evidence indicates that the P2X7 receptor (P2X7R), a nucleotide-gated ionotropic channel primarily involved in the inflammatory response, may also have a key role in the development of tissue fibrosis in different body districts. This study was aimed at investigating P2X7R expression and function in promoting a fibrogenic phenotype in dermal fibroblasts from SSc patients, also analyzing putative underlying mechanistic pathways. Methods: Fibroblasts were isolated by skin biopsy from 9 SSc patients and 8 healthy controls. P2X7R expression, and function (cytosolic free Ca(2+) fluxes, α-smooth muscle actin [α-SMA] expression, cell migration, and collagen release) were studied. Moreover, the role of cytokine (interleukin-1β, interleukin-6) and connective tissue growth factor (CTGF) production, and extracellular signal-regulated kinases (ERK) activation in mediating P2X7R-dependent pro-fibrotic effects in SSc fibroblasts was evaluated. Results: P2X7R expression and Ca(2+) permeability induced by the selective P2X7R agonist 2′-3′-O-(4-benzoylbenzoyl)ATP (BzATP) were markedly higher in SSc than control fibroblasts. Moreover, increased αSMA expression, cell migration, CTGF, and collagen release were observed in lipopolysaccharides-primed SSc fibroblasts after BzATP stimulation. While P2X7-induced cytokine changes did not affect collagen production, it was completely abrogated by inhibition of the ERK pathway. Conclusion: In SSc fibroblasts, P2X7R is overexpressed and its stimulation induces Ca(2+)-signaling activation and a fibrogenic phenotype characterized by increased migration and collagen production. These data point to the P2X7R as a potential, novel therapeutic target for controlling exaggerated collagen deposition and tissue fibrosis in patients with SSc. |
format | Online Article Text |
id | pubmed-5602350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56023502017-09-27 Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts Gentile, Daniela Lazzerini, Pietro E. Gamberucci, Alessandra Natale, Mariarita Selvi, Enrico Vanni, Francesca Alì, Alessandra Taddeucci, Paolo Del-Ry, Silvia Cabiati, Manuela Della-Latta, Veronica Abraham, David J. Morales, Maria A. Fulceri, Rosella Laghi-Pasini, Franco Capecchi, Pier L. Front Pharmacol Pharmacology Objectives: Systemic sclerosis (SSc) is a connective tissue disorder presenting fibrosis of the skin and internal organs, for which no effective treatments are currently available. Increasing evidence indicates that the P2X7 receptor (P2X7R), a nucleotide-gated ionotropic channel primarily involved in the inflammatory response, may also have a key role in the development of tissue fibrosis in different body districts. This study was aimed at investigating P2X7R expression and function in promoting a fibrogenic phenotype in dermal fibroblasts from SSc patients, also analyzing putative underlying mechanistic pathways. Methods: Fibroblasts were isolated by skin biopsy from 9 SSc patients and 8 healthy controls. P2X7R expression, and function (cytosolic free Ca(2+) fluxes, α-smooth muscle actin [α-SMA] expression, cell migration, and collagen release) were studied. Moreover, the role of cytokine (interleukin-1β, interleukin-6) and connective tissue growth factor (CTGF) production, and extracellular signal-regulated kinases (ERK) activation in mediating P2X7R-dependent pro-fibrotic effects in SSc fibroblasts was evaluated. Results: P2X7R expression and Ca(2+) permeability induced by the selective P2X7R agonist 2′-3′-O-(4-benzoylbenzoyl)ATP (BzATP) were markedly higher in SSc than control fibroblasts. Moreover, increased αSMA expression, cell migration, CTGF, and collagen release were observed in lipopolysaccharides-primed SSc fibroblasts after BzATP stimulation. While P2X7-induced cytokine changes did not affect collagen production, it was completely abrogated by inhibition of the ERK pathway. Conclusion: In SSc fibroblasts, P2X7R is overexpressed and its stimulation induces Ca(2+)-signaling activation and a fibrogenic phenotype characterized by increased migration and collagen production. These data point to the P2X7R as a potential, novel therapeutic target for controlling exaggerated collagen deposition and tissue fibrosis in patients with SSc. Frontiers Media S.A. 2017-09-13 /pmc/articles/PMC5602350/ /pubmed/28955239 http://dx.doi.org/10.3389/fphar.2017.00638 Text en Copyright © 2017 Gentile, Lazzerini, Gamberucci, Natale, Selvi, Vanni, Alì, Taddeucci, Del-Ry, Cabiati, Della-Latta, Abraham, Morales, Fulceri, Laghi-Pasini and Capecchi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Gentile, Daniela Lazzerini, Pietro E. Gamberucci, Alessandra Natale, Mariarita Selvi, Enrico Vanni, Francesca Alì, Alessandra Taddeucci, Paolo Del-Ry, Silvia Cabiati, Manuela Della-Latta, Veronica Abraham, David J. Morales, Maria A. Fulceri, Rosella Laghi-Pasini, Franco Capecchi, Pier L. Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts |
title | Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts |
title_full | Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts |
title_fullStr | Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts |
title_full_unstemmed | Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts |
title_short | Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts |
title_sort | searching novel therapeutic targets for scleroderma: p2x7-receptor is up-regulated and promotes a fibrogenic phenotype in systemic sclerosis fibroblasts |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602350/ https://www.ncbi.nlm.nih.gov/pubmed/28955239 http://dx.doi.org/10.3389/fphar.2017.00638 |
work_keys_str_mv | AT gentiledaniela searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT lazzerinipietroe searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT gamberuccialessandra searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT natalemariarita searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT selvienrico searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT vannifrancesca searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT alialessandra searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT taddeuccipaolo searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT delrysilvia searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT cabiatimanuela searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT dellalattaveronica searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT abrahamdavidj searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT moralesmariaa searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT fulcerirosella searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT laghipasinifranco searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts AT capecchipierl searchingnoveltherapeutictargetsforsclerodermap2x7receptorisupregulatedandpromotesafibrogenicphenotypeinsystemicsclerosisfibroblasts |